Calcium channel blockers may improve treatment for pancreatic cancer patients receiving gemcitabine-based chemotherapy, according to recent findings published in the Proceedings of the National ...

Dihydropyridine calcium channel blockers may be linked to worse kidney outcomes for patients with type 2 diabetes, according to study data presented at the European Renal Association Congress in ...

For adults with type 2 diabetes receiving guideline-directed renin-angiotensin inhibitors (RASi) and sodium-glucose ...

Dihydropyridine calcium-channel-blockers (DCCBs), used to treat high blood pressure, could speed up the progression of kidney ...

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these ...

A commonly prescribed blood pressure drug is now under scrutiny after researchers found a possible link to worsening kidney ...

Calcium channel blockers constitute a class of antihypertensive agents that inhibit voltage-dependent calcium influx in vascular smooth muscle and renal cells. In patients with hypertensive kidney ...

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these ...

A woman with hopes to conceive was diagnosed with severe vasospastic angina (VSA); however, she was able to carry a healthy baby to full term without angina attacks after starting treatment of a ...

I have found that some patients with depression seem to improve when calcium blockers are discontinued. Are there any data to support this? What would be your preference as a replacement for a calcium ...

Myotonic dystrophy is one of the most common forms of muscular dystrophy. It is a genetic condition that causes progressive muscle weakness and wasting. No treatments currently exist that slow the ...